Saturday, February 6, 2010

mgi pharma updates

Encyclopedia.com -- Online dictionary and encyclopedia of facts, information, and biographies
Search over 100 encyclopedias and dictionaries:
Search
Research categories Close categories
Research categories

* Earth and the Environment
* History
* Literature and the Arts
* Medicine
* People
* Philosophy and Religion

* Places
* Plants and Animals
* Science and Technology
* Social Sciences and the Law
* Sports and Everyday Life

View all reference sources at Encyclopedia.com
Free reference entries

* A
* B
* C
* D
* E
* F
* G
* H
* I
* J
* K
* L
* M
* N
* O
* P
* Q
* R
* S
* T
* U
* V
* W
* X
* Y
* Z
* #

Business Wire
MGI PHARMA Updates Outlook for First Quarter.
Business Wire | April 13, 2006 | COPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information) Copyright
Ads by Google

Full-Text Online Library
Research online. Books, journals, articles at Questia Online Library.
www.Questia.com

What You Need to Know
Unbiased news for the pharmaceutical industry.
www.ThePinkSheetDaily.com

Work At Pfizer
India's largest Jobs and Recruitment Search. Apply Now!
www.TimesJobs.com

MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN), an oncology- and acute care-focused biopharmaceutical company, today announced that for the first quarter of 2006, it expects total revenue to be approximately $78 million and loss per share in the range of ($0.03) to ($0.05).

Sales of Aloxi(R) (palonosetron hydrochloride) Injection are expected to total approximately $63 million for the first quarter of 2006. The Company had previously indicated that it did not expect Aloxi Injection sales to increase from the fourth quarter of 2005 to the first quarter of 2006, and had…

Read the rest of this article with a FREE trial to HighBeam Research
Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)
{#foreach $T.Malts as record} {#/for}
{$T.record.Title}
{$T.record.PublictionSource} {$T.record.Teaser}


Loading
Searching…
Business Wire MGI PHARMA And HELSINN HEALTHCARE SA Summarize Aloxi Injection Clinical Data...
Business Wire ...the impact of treatment with Aloxi injection on various quality-of...maintenance of efficacy of Aloxi injection in patients weighing more...safety of repeat doses of Aloxi injection. MGI PHARMA and HELSINN are also sponsoring...
Biomedical Market Newsletter MGI Pharma Inc. (NASDAQ:MOGN).(Distribution Deals)(markets Aloxi injection...
Newspaper article from: Biomedical Market Newsletter MINNEAPOLIS MN -- SEPT 15 2003--Began to sell and market its Aloxi injection product in the US, which was approved by the FDA on July 25 2003 at a fixed dose of 0.25 mg for the prevention of acute nausea...
Business Wire Aloxi Injection 2004 Sales Results Expected to Exceed Previous Guidance.
Business Wire ...March 17, 2004 MGI PHARMA, INC. (Nasdaq...12 million. MGI PHARMA now anticipates sales of Aloxi injection to be in the range...treatments with Aloxi injection have occurred since...executive officer of MGI PHARMA. "We are very...
Biotech Business Week Aloxi injection 2004 sales results expected to exceed previous guidance.
Newspaper article from: Biotech Business Week ...com & NewsRx.net) -- MGI Pharma, Inc., (MOGN) announced that it expects sales of Aloxi injection for the first quarter of...guidance of $12 million. MGI Pharma now anticipates sales of Aloxi injection to be in the range of...
Business Wire MGI PHARMA Reports Second Quarter Financial Results.
Business Wire ...increases in Aloxi injection sales...officer of MGI PHARMA. "We are...Injection MGI PHARMA markets Aloxi injection at a dose...000 vials of Aloxi injection were pulled...announced today, MGI PHARMA and Alpharma...
Business Wire MGI PHARMA Reports First Quarter 2004 Financial Results.
Business Wire ...officer of MGI PHARMA. "We estimate...000 doses of Aloxi injection have been...Injection Update MGI PHARMA markets Aloxi injection at a dose...placement of MGI PHARMA's senior...million. -- Aloxi injection was incorporated...
Business Wire MGI PHARMA Provides Corporate Update; 2005 Aloxi(R) Injection Sales Increase...
Business Wire ...expects sales of Aloxi injection for 2005 to...3, 2005, MGI PHARMA expects to...submission. MGI PHARMA now plans...to evaluate Aloxi injection for the prevention...and CEO of MGI PHARMA. "Aloxi injection sales grew...
Biotech Business Week Aloxi injection incorporated into NCCN antiemetic guidelines.
Newspaper article from: Biotech Business Week ...NewsRx.net) -- MGI Pharma, Inc., (MOGN...NCCN identified Aloxi injection as the "preferred...In addition, Aloxi injection is recommended...clinical benefit of Aloxi injection in preventing...executive officer of MGI Pharma. NCCN Clinical...
Business Wire Aloxi Injection Incorporated into NCCN Antiemetic Guidelines.
Business Wire ...March 11, 2004 MGI PHARMA, INC. (Nasdaq...NCCN identified Aloxi injection as the "preferred...In addition, Aloxi injection is recommended...clinical benefit of Aloxi injection in preventing...executive officer of MGI PHARMA. NCCN Clinical...
Business Wire MGI PHARMA Reports Second Quarter Results.
Business Wire ...share. At June 30, 2005, MGI PHARMA's unrestricted cash and marketable...totaled $218.8 million. "MGI PHARMA continued to leverage its commercial...and chief executive officer of MGI PHARMA. "Aloxi injection holds the number one share position...

For more facts and information, see all results

Find more facts and information related to the article MGI PHARMA Updates Outlook for First Quarter.


Search over 100 encyclopedias and dictionaries:
Search

HighBeam™ Research, Inc. © Copyright 2010. All rights reserved.

* Encyclopedia.com home page
* About us
* Help
* Site feedback
* Privacy policy
* Terms and conditions

The Encyclopedia.com advertising network includes: womensforum.com GlamFamily

No comments:

Post a Comment